Doxorubicin Hydrochloride Injection, Suspension, Liposomal
Product Images NDC 68001-629

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Doxorubicin Hydrochloride (NDC 68001-629). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Doxorubicin Hydrochloride (1a930cb7 5363 4229 9f39 53edc07a43d6 01)

FDA Label Image

Mpeg-dspe (1a930cb7 5363 4229 9f39 53edc07a43d6 02)

FDA Label Image

Hspc (1a930cb7 5363 4229 9f39 53edc07a43d6 03)

FDA Label Image

Pegylated Liposome (1a930cb7 5363 4229 9f39 53edc07a43d6 04)

FDA Label Image

Figure 1 (1a930cb7 5363 4229 9f39 53edc07a43d6 05)

FDA Label Image

Doxo 20mg/10ml 10 mL Vial Label (1a930cb7 5363 4229 9f39 53edc07a43d6 06)

This is information related to the storage and usage of Doxorubicin Hydrochloride Liposome Injection manufactured by BluePoint Laboratories. The medication should be refrigerated at 2° to 8°C (36° to 46° F) and should not be frozen. The recommended dosage, dilution process, and administration instructions are provided in the package insert. It is a cytotoxic medication in a liposomal formulation for intravenous infusion only after dilution. The text emphasizes not substituting the liposomal formulation with other versions of Doxorubicin Hydrochloride.*

FDA Label Image

Doxo 20mg/10ml 10 mL Vial Carton (1a930cb7 5363 4229 9f39 53edc07a43d6 07)

FDA Label Image

Doxo 50mg/25ml 10 mL Vial Label (1a930cb7 5363 4229 9f39 53edc07a43d6 08)

This text is a set of storage instructions and dosage recommendations for Doxorubicin Hydrochloride Liposome Injection. It also includes details about dilution using 5% Dextrose Injection, USP. The package insert should be consulted for specific dosage information. A National Drug Code (NDC) number is provided along with indication for intravenous infusion after dilution. It is advised to discard any unused portion. The product is a liposomal formulation and not to be substituted for Doxorubicin Hydrochloride. The text also includes the manufacturer's information for the product.*

FDA Label Image

Doxo 50mg/25ml 10 mL Vial Carton (1a930cb7 5363 4229 9f39 53edc07a43d6 09)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.